Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction: the BENEFIT-AMI Multicenter Prospective Registry

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

To validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively designed hospital-based registry. To characterize those factors that contribute to the progression of post-MI NOAF burden. To establish a prediction model for the risk stratification of patients with NOAF complicating AMI. To explore the clinical usefulness of NOAF burden in guiding the anticoagulation therapy among patients with post-MI NOAF.

Who May Be Eligible (Plain English)

Who May Qualify: - Adult patients (\>18 years old); - Patient with AMI (including STEMI and NSTEMI) who developed NOAF during the index hospitalization; - Patients must have received in-hospital CEM for at least 5 days; - Patients must give willing to sign a consent form. Who Should NOT Join This Trial: - Patients with a medical history of pre-existing AF; - Patients with a medical history of rheumatic valvular disease; - Patients with a medical history of sick sinus syndrome; - Patients undergoing emergent coronary artery bypass surgery; - Patients who suffer malignant tumors with an expected lifetime less than 1 year ; - Patients who refuse to receive CEM during hospitalization and the data of heart rhythm cannot be retrieved; - Patients who refuse to receive percutaneous coronary intervention (PCI) or have contraindications for PCI; - Patients who have died during the index hospitalization. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Adult patients (\>18 years old); * Patient with AMI (including STEMI and NSTEMI) who developed NOAF during the index hospitalization; * Patients must have received in-hospital CEM for at least 5 days; * Patients must give informed consent. Exclusion Criteria: * Patients with a medical history of pre-existing AF; * Patients with a medical history of rheumatic valvular disease; * Patients with a medical history of sick sinus syndrome; * Patients undergoing emergent coronary artery bypass surgery; * Patients who suffer malignant tumors with an expected lifetime less than 1 year ; * Patients who refuse to receive CEM during hospitalization and the data of heart rhythm cannot be retrieved; * Patients who refuse to receive percutaneous coronary intervention (PCI) or have contraindications for PCI; * Patients who have died during the index hospitalization.

Treatments Being Tested

DEVICE

Continuous Electronic Monitor

All patients with NOAF complicating AMI will receive at least 5 days electronic monitoring for the evaluation of NOAF burden

Locations (5)

Kaifeng Central Hospital
Kaifeng, Henan, China
Luoyang Central Hospital
Luoyang, Henan, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Department of Cardiology, Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China
Shanghai Seventh People's Hospital
Shanghai, Shanghai Municipality, China